Get started
Author

Anne‐Sophie Litmeyer

Observed names: A.-S. Litmeyer, Anne-Sophie Litmeyer, Litmeyer, Anne-Sophie
ORCID: 0009-0009-4710-6746
Observed ORCID: 0009-0009-4710-6746
OpenAlex ID: A5018470917
DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms
2025 · Maxime Schmitt, Hanibal Bohnenberger, et al. · Endocrine Pathology · 28
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
2025 · Niklas Gremke, Isabelle Besong, et al. · Signal Transduction and Targeted Therapy · 25
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis
2024 · Sebastian Foersch, Maxime Schmitt, et al. · The Journal of Pathology Clinical Research · 22
The nonconservative CD177 single‐nucleotide polymorphism c.1291G>A is a genetic determinant for human neutrophil antigen‐2 atypical/low expression and deficiency
2019 · Jianming Wu, Yunfang Li, et al. · Transfusion · 20
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas—proposal for a new pT3a/pT3b subclassification
2022 · Sebastian Foersch, Corinna Lang-Schwarz, et al. · British Journal of Cancer · 15
PDF
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis
2024 · Niklas Gremke, Fiona R. Rodepeter, et al. · Cancers · 14
PDF
High expression of insulinoma‐associated protein 1 ( INSM1 ) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
2023 · Anne‐Sophie Litmeyer, Björn Konukiewitz, et al. · The Journal of Pathology Clinical Research · 13
PDF
Stroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria
2025 · Sebastian Foersch, Nuwar Harb, et al. · Histopathology · 10
PDF
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2− breast cancer
2026 · Luise von Wichert, Alina Stroh, et al. · Cell Death and Disease · 4
PDF
The CD177 c.1291A Allele Leads to a Loss of Membrane Expression and Mimics a CD177-Null Phenotype
2024 · Annalena Traum, Stefanie Jehle, et al. · International Journal of Molecular Sciences · 4
PDF
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline – relevance for additional therapeutic options
2026 · Nuwar Harb, Marcel Romey, et al. · Cancer Genetics · 1
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification
2025 · Kristin Galas, Moritz Gleitsmann, et al. · npj Breast Cancer · 1
PDF
Abstract PO5-25-12: CDH1 mutations predict resistance to neoadjuvant taxane therapy
2024 · Stian Knappskog, Reham Helwa, et al. · Cancer Research · 1
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification
2026 · Paul Jank, Maximilian J. Krämer, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
PDF
Overcoming PI3Kinase inhibitor resistance in breast cancer: mechanistic insights, metabolic vulnerabilities and clinical correlations
2024 · N. Gremke, I. Besong, et al. · Geburtshilfe und Frauenheilkunde
CDH1 mutations predict resistance to neoadjuvant taxane therapy
2024 · Knappskog, Stian, Helwa, Reham, et al. · RWTH Publications (RWTH Aachen)
Abstract P4-04-14: Immunological markers in patients with breast cancer occurring during pregnancy - Results from GBG BCP study
2022 · Kristin Galas, Moritz Gleitsmann, et al. · Cancer Research
Works count: 17
Citation count: 158
H-index: 8
I10-index: 8
Year
Topic
Type